The National Institute of Health and Care Excellence (NICE) have published new guidance for the month of September 2015. This month there is one clinical guideline and one technology appraisal that impact upon primary care.
The Coeliac Disease guideline covers the recognition, assessment and management of coeliac disease in children, young people and adults.
The Edoxaban technology appraisal recommends this treatment as an option for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation who have one or more risk factors.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« Gliptins may cause severe joint pain||SMC Update - October 2015 »|